News | Drug-Eluting Balloons | December 06, 2016

Spectranetics Receives CE Mark for Stellarex 0.014-inch Drug-Coated Balloon

Device provides additional treatment option for small vessels, below-the-knee disease and challenging critical limb ischemia

Spectranetics, Stellarex 0.014-inch DCB, CE Mark

December 6, 2016 — The Spectranetics Corp. announced in late November that its Stellarex 0.014-inch drug-coated angioplasty balloon (DCB) has received the CE mark. The device is designed to treat small vessels, below-the-knee disease and challenging critical limb ischemia (CLI) in patients. 

The combination of the currently available Stellarex 0.035-inch and the new 0.014-inch line available in Europe expands Spectranetics’ comprehensive portfolio of next-generation DCBs to treat complex disease states across the lower extremities.

CLI afflicts over 3 million people in the United States and Europe. The critical unmet need of this complex patient population is inhibition of restenosis, which commonly occurs within three to six months of treatment and can lead to high rates of non-wound healing, re-intervention and amputation.

"Now available on a 0.014-inch balloon platform, Stellarex represents a latest-generation DCB backed by compelling evidence in the fem-pop arteries. It holds strong promise to deliver safety and efficacy in the notoriously challenging infrapopliteal district,” said Prof. Dierk Scheinert of Universitätsklinikum in Leipzig, Germany.

For more information: www.spectranetics.com


Additional Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
Subscribe Now